pDCs isolated from cutaneous lupus erythematosus and SLE patients administered HCQ had significantly lower IFNα production upon TLR7 or TLR9 stimulation compared with patients not receiving HCQ (80, 81). This evidence concerns the gene TLR9 and systemic lupus erythematosus.